Skip to main content
SpringerLink
Log in

Antipsychotics

Hyperprolactinaemia and pulmonary thromboembolism: 7 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Fisekovic S, Celik D.Is hyperprolactinemia a risk factor for pulmonary thromboembolism (PTE) in patients treated with antipsychotic drugs? HealthMED 6: 2234-2238, No. 6, 2012 - Bosnia-Herzegovina

Download references

Additional information

Key words

Chlorpromazine; Fluphenazine; Thioridazine; adverse reactions; Haloperidol; drug-induced; Pulmonary-embolism; Hyperprolactinaemia; Clozapine; Risperidone; Olanzapine

An event is serious (FDA MedWatch definition) when the patient outcome is: death; life-threatening; hospitalisation; disability; congenital anomaly; requires intervention to prevent permanent impairment or damage

Rights and permissions

Reprints and permissions

About this article

Cite this article

Antipsychotics. React. Wkly. 1426, 10 (2012). https://doi.org/10.2165/00128415-201214260-00033

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214260-00033

Keywords

Search

Navigation